Abstract
Extracellular matrix remodelling of the adipose tissue has a pivotal role in the pathophysiology of obesity. Galectin-3 (Gal-3) is increased in obesity and mediates inflammation and fibrosis in the cardiovascular system. However, the effects of Gal-3 on adipose tissue remodelling associated with obesity remain unclear. Male Wistar rats were fed either a high-fat diet (33.5% fat) or a standard diet (3.5% fat) for 6 weeks. Half of the animals of each group were treated with the pharmacological inhibitor of Gal-3, modified citrus pectin (MCP; 100 mg kg−1 per day) in the drinking water. In adipose tissue, obese animals presented an increase in Gal-3 levels that were accompanied by an increase in pericellular collagen. Obese rats exhibited higher adipose tissue inflammation, as well as enhanced differentiation degree of the adipocytes. Treatment with MCP prevented all the above effects. In mature 3T3-L1 adipocytes, Gal-3 (10−8m) treatment increased fibrosis, inflammatory and differentiation markers. In conclusion, Gal-3 emerges as a potential therapeutic target in adipose tissue remodelling associated with obesity and could have an important role in the development of metabolic alterations associated with obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alkhouli N, Mansfield J, Green E, Bell J, Knight B, Liversedge N et al. The mechanical properties of human adipose tissues and their relationships to the structure and composition of the extracellular matrix. Am J Physiol Endocrinol Metab 2013; 305: E1427–E1435.
Buechler C, Krautbauer S, Eisinger K . Adipose tissue fibrosis. World J Diabetes 2015; 6: 548–553.
Nakajima I, Muroya S, Tanabe R, Chikuni K . Positive effect of collagen V and VI on triglyceride accumulation during differentiation in cultures of bovine intramuscular adipocytes. Differentiation 2002; 70: 84–91.
Rhodes DH, Pini M, Castellanos KJ, Montero-Melendez T, Cooper D, Perretti M et al. Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function. Obesity (Silver Spring) 2013; 21: 310–319.
Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN et al. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab 2010; 95: 1404–1411.
Baek JH, Kim SJ, Kang HG, Lee HW, Kim JH, Hwang KA et al. Galectin-3 activates PPARgamma and supports white adipose tissue formation and high-fat diet-induced obesity. Endocrinology 2015; 156: 147–156.
Flotte TJ, Springer TA, Thorbecke GJ . Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol 1983; 111: 112–124.
Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sadaba JR et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail 2015; 3: 59–67.
Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, de Boer RA et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol 2013; 33: 67–75.
Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG et al. Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 2013; 62: 1932–1944.
Pang J, Rhodes DH, Pini M, Akasheh RT, Castellanos KJ, Cabay RJ et al. Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. PLoS One 2013; 8: e57915.
Kiwaki K, Novak CM, Hsu DK, Liu FT, Levine JA . Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity (Silver Spring) 2007; 15: 32–39.
Martinez-Martinez E, Cachofeiro V, Rousseau E, Alvarez V, Calvier L, Fernandez-Celis A et al. Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation. Mol Cell Endocrinol 2015; 411: 20–27.
Makki K, Froguel P, Wolowczuk I . Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013; 2013: 139239.
Daniele G, Guardado Mendoza R, Winnier D, Fiorentino TV, Pengou Z, Cornell J et al. The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014; 51: 123–131.
Pierleoni C, Verdenelli F, Castellucci M, Cinti S . Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem 1998; 42: 183–188.
Acknowledgements
This work was supported by Miguel Servet contract CP13/00221, Plan Estatal I+D+I 2013–2016, INSERM, Programme National de Recherche Cardiovasculaire, Région Lorraine, Fondo de Investigaciones Sanitarias (PI12/01729) and Red de Investigación Cardiovascular (RD12/0042/0033).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Martínez-Martínez, E., Calvier, L., Rossignol, P. et al. Galectin-3 inhibition prevents adipose tissue remodelling in obesity. Int J Obes 40, 1034–1038 (2016). https://doi.org/10.1038/ijo.2016.19
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2016.19
This article is cited by
-
Role of galectin-3 as a biomarker in obstructive sleep apnea: a systematic review and meta-analysis
Sleep and Breathing (2023)
-
Exploring the Mechanistic Link Between Obesity and Heart Failure
Current Diabetes Reports (2023)
-
The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease
Cardiovascular Diabetology (2022)
-
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial
Clinical Research in Cardiology (2022)
-
Low Molecular Pectin Inhibited the Lipid Accumulation by Upregulation of METTL7B
Applied Biochemistry and Biotechnology (2021)